129 related articles for article (PubMed ID: 31229268)
1. p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration.
Chen XF; Pan YS; Zheng B; Lu Q
Biochem Biophys Res Commun; 2019 Aug; 516(2):466-473. PubMed ID: 31229268
[TBL] [Abstract][Full Text] [Related]
2. Targeting p38γ to inhibit human colorectal cancer cell progression.
Su C; Sun Q; Liu S; Wang H; Feng L; Cao Y
Biochem Biophys Res Commun; 2019 Sep; 517(1):172-179. PubMed ID: 31349971
[TBL] [Abstract][Full Text] [Related]
3. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
4. p38γ overexpression promotes osteosarcoma cell progression.
Shi C; Cheng WN; Wang Y; Li DZ; Zhou LN; Zhu YC; Zhou XZ
Aging (Albany NY); 2020 Sep; 12(18):18384-18395. PubMed ID: 32970611
[TBL] [Abstract][Full Text] [Related]
5. SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth.
Wang TB; Geng M; Jin H; Tang AG; Sun H; Zhou LZ; Chen BH; Shen G; Sun Q
Cell Death Dis; 2021 Jul; 12(8):717. PubMed ID: 34285190
[TBL] [Abstract][Full Text] [Related]
6. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
7. LncRNA THOR promotes human renal cell carcinoma cell growth.
Ye XT; Huang H; Huang WP; Hu WL
Biochem Biophys Res Commun; 2018 Jun; 501(3):661-667. PubMed ID: 29752937
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38delta/gamma, cyclooxygenase-2 down-regulation, and translocation of apoptosis-inducing factor.
Ambrose M; Ryan A; O'Sullivan GC; Dunne C; Barry OP
Mol Pharmacol; 2006 Jun; 69(6):1879-90. PubMed ID: 16543392
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
12. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
13. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
[TBL] [Abstract][Full Text] [Related]
15. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
16. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
18. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
19. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
20. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
Shi J; Zhang D; Zhong Z; Zhang W
Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
